Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 9/20 | 0.48 |
| ▸ | CTSS | P25774 | 6/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3773280 | 1.00 | CTSK (0.48) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL863895 | 1.00 | CTSK (0.48) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL18261684 | 0.94 | CTSK (0.44) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2306568 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL10606035 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2398972 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL6409351 | 0.92 | CTSK (0.47) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21685690 | 0.92 | FOLH1 (0.42) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21685691 | 0.92 | FOLH1 (0.42) | CTSKCTSSCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL9196011 | 0.90 | CTSK (0.50) | CTSKCTSSCTSLCTSBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 506 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136804-A | Glutamic acid-N-carboxyl-cyclic anhydride monomer containing ethyl nitrate group, polymer thereof and application of glutamic acid-N-carboxyl-cyclic anhydride monomer serving as nitric oxide donor | 武汉理工大学 | 2025-06-13 | — | — | CN | claimed |
| CN-120004868-A | Novel probe for monitoring activity of glutamyl transpeptidase as well as preparation method and application thereof | 宁波大学附属第一医院 | 2025-05-16 | — | — | CN | claimed |
| CN-119874690-A | Gamma-glutamyl transferase and mitochondrial viscosity dual-response fluorescent probe and preparation method and application thereof | 西北农林科技大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119331049-B | Dimeric labelling precursors targeting CXCR4 receptor and radiotracers derived therefrom | 山东大学 | 2025-04-04 | — | — | CN | claimed |
| CN-118370722-B | Responsive nano micelle for enhancing deep penetration of tumor as well as preparation method and application thereof | 海东市第二人民医院 | 2025-03-14 | — | — | CN | claimed |
| US-20250042939-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | SHENYANG XINGQI PHARMACEUTICAL CO., LTD. (CN) | 2025-02-06 | — | — | US | claimed |
| CN-119331049-A | Dimeric labelling precursors targeting CXCR4 receptor and radiotracers derived therefrom | 山东大学 | 2025-01-21 | — | — | CN | claimed |
| CN-119219667-A | Aminopeptidase activated photodynamic photosensitizer and preparation method and application thereof | 山西大学 | 2024-12-31 | — | — | CN | claimed |
| EP-4455156-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | Shenyang Xingqi Pharmaceutical Co., Ltd. (CN) | 2024-10-30 | — | — | EP | claimed |
| CN-118370722-A | Responsive nano micelle for enhancing deep penetration of tumor as well as preparation method and application thereof | 海东市第二人民医院 | 2024-07-23 | — | — | CN | claimed |
| CN-114452404-B | Vesicle with anchoring and charge overturning functions and preparation and application thereof | 中山大学附属第三医院（中山大学肝脏病医院） | 2023-09-08 | — | — | CN | claimed |
| WO-2023116664-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | 沈阳兴齐眼药股份有限公司 | 2023-06-29 | — | — | WO | claimed |
| CN-116217925-A | Nanometer medicine for inducing mitochondrial dysfunction and reversing multi-medicine resistance by taking red blood cell for stool transport | 宁波大学 | 2023-06-06 | — | — | CN | claimed |
| CN-116217486-A | Fluorescent compound and preparation method and application thereof | 厦门大学 | 2023-06-06 | — | — | CN | claimed |
| CN-114316266-B | Reduction-responsive polymer prodrug achieving deep delivery by targeting CAIX and transcytosis | 宁波大学 | 2023-05-26 | — | — | CN | claimed |
| CN-113388004-B | Tumor protease activated self-assembly molecular probe and preparation method and application thereof | 江苏省原子医学研究所 | 2023-04-07 | — | — | CN | claimed |
| CN-115040495-A | Oral nano drug delivery system mediated by small molecular nutrient substances | 四川大学 | 2022-09-13 | — | — | CN | claimed |
| CN-114316266-A | Reduction-responsive prodrug for realizing deep delivery by targeting CAIX and transcytosis | 宁波大学 | 2022-04-12 | — | — | CN | claimed |
| CN-111253464-B | Gamma-glutamyl transpeptidase targeted molecular probe and preparation method and application thereof | 江苏省原子医学研究所 | 2022-02-01 | — | — | CN | claimed |
| US-5373014-A | Antibody inhibitor | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-12-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250042939-A1 | PREPARATION METHOD FOR OXIDIZED GLUTATHIONE AND CRYSTAL FORM AND IMPURITY THEREOF | GPX4, GPX1, GSTM2 | CTSK 2783/4885CTSS 2739/4885CYP1A2 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.